SCHEMBL1474875

SCHEMBL1474875

C=CCn1[c]nnc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6125510 0.64
SCHEMBL1927501 0.64
SCHEMBL1828282 0.62
SCHEMBL17186581 0.62
SCHEMBL333505 0.60
SCHEMBL17803267 0.58
SCHEMBL11097856 0.57
SCHEMBL458090 0.56
SCHEMBL849669 0.56
SCHEMBL7190504 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160280691-A1 TRIAZOLE INTERMEDIATES USEFUL IN THE SYNTHESIS OF PROTECTED N-ALKYLTRIAZOLECARBALDEHYDES BIOMARIN PHARMACEUTICAL INC. 2016-09-29 US claimed
EP-3066084-A1 TRIAZOLE INTERMEDIATES USEFUL IN THE SYNTHESIS OF PROTECTED N-ALKYLTRIAZOLECARBALDEHYDES Medivation Technologies, Inc. (US) 2016-09-14 EP claimed
CN-105916846-A Triazole intermediates useful in the synthesis of protected N-alkyltriazolecarbaldehydes 麦迪韦逊科技有限公司 2016-08-31 CN claimed
WO-2015069851-A1 TRIAZOLE INTERMEDIATES USEFUL IN THE SYNTHESIS OF PROTECTED N-ALKYLTRIAZOLECARBALDEHYDES BIOMARIN PHARMACEUTICAL INC. (US) 2015-05-14 WO claimed
EP-0090366-A1 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1983-10-05 EP claimed
US-20160280691-A1 TRIAZOLE INTERMEDIATES USEFUL IN THE SYNTHESIS OF PROTECTED N-ALKYLTRIAZOLECARBALDEHYDES BIOMARIN PHARMACEUTICAL INC. 2016-09-29 US disclosed
EP-3066084-A1 TRIAZOLE INTERMEDIATES USEFUL IN THE SYNTHESIS OF PROTECTED N-ALKYLTRIAZOLECARBALDEHYDES Medivation Technologies, Inc. (US) 2016-09-14 EP disclosed
CN-105916846-A Triazole intermediates useful in the synthesis of protected N-alkyltriazolecarbaldehydes 麦迪韦逊科技有限公司 2016-08-31 CN disclosed
WO-2015069851-A1 TRIAZOLE INTERMEDIATES USEFUL IN THE SYNTHESIS OF PROTECTED N-ALKYLTRIAZOLECARBALDEHYDES BIOMARIN PHARMACEUTICAL INC. (US) 2015-05-14 WO disclosed
US-7915241-B2 Reacting a sulfone intermediate, possessing a (5E) or (5Z) configuration with an aldehyde having an (R) or an (S) configuration in the presence of a strong base, in an aprotic solvent; synthetic analog of vitamin D3-calcipotriol, biologically active compound used in medical treatment INSTYTUT FARMACEUTYCZNY (PL) 2011-03-29 US disclosed
US-20050119241-A1 Preparation of 24 alkyl analogs of cholecalciferol and non-racemic compounds INSTYTUT FARMACEUTYCZNY (PL) 2005-06-02 US disclosed
US-RE35754-E FOR TREATING BACTERIAL INFECTIONS HOECHST AKTIENGESELLSCHAFT (DE) 1998-03-24 US disclosed
EP-0090366-A1 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1983-10-05 EP disclosed
US-4399131-A Cephem derivatives HOECHST AG (DE) 1983-08-16 US disclosed
US-4399135-A ANTIBIOTICS RHONE-POULENC INDUSTRIES (FR) 1983-08-16 US disclosed
US-4399135-A ANTIBIOTICS RHONE-POULENC INDUSTRIES (FR) 1983-08-16 US disclosed
US-4370478-A Oxacephalosporins RHONE-POULENC INDUSTRIES (FR) 1983-01-25 US disclosed
US-4369315-A ANTIBIOTIC RHONE-POULENC INDUSTRIES (FR) 1983-01-18 US disclosed
US-4369314-A Oxacephalosporins RHONE-POULENC INDUSTRIES (FR) 1983-01-18 US disclosed
US-4278793-A ANTIBIOTICS, BACTERICIDES HOECHST AKTIENGESELLSCHAFT (DE) 1981-07-14 US disclosed